Acadia Healthcare (ACHC) Reports In-Line Q4 EPS, Offers Q1 & FY Guidance

Acadia Healthcare (NASDAQ: ACHC) reported Q4 EPS of $0.59, in-line with the analyst estimate of $0.59. Revenue for the quarter came in at $495.3 million versus the consensus estimate of $488 million.

GUIDANCE:

Acadia Healthcare sees Q1 2016 EPS of $0.53-$0.54, versus the consensus of $0.60.

Acadia Healthcare sees FY2016 EPS of $2.81-$2.86, versus the consensus of $2.85.

For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Morgan Stanley Resumes Global Payments (GPN) at Equalweight
• Pfizer reaffirms 2026 guidance after CFO transition news